Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models
Open Access
- 22 May 2007
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 96 (12), 1862-1870
- https://doi.org/10.1038/sj.bjc.6603806
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Radioimmunotherapy targeting the extra domain B of fibronectin in C6 rat gliomas: a preliminary study about the therapeutic efficacy of iodine-131-labeled SIP(L19)Nuclear Medicine and Biology, 2006
- Antibody-guided radiation therapy of cancerCancer and Metastasis Reviews, 2005
- Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude miceEuropean Journal Of Cancer, 2005
- Engineered vascular‐targeting antibody‐interferon‐γ fusion protein for cancer therapyInternational Journal of Cancer, 2005
- Molecular targeting of angiogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2004
- Expression of the Extra Domain B of Fibronectin, a Marker of Angiogenesis, in Head and Neck TumorsThe Laryngoscope, 2003
- Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED‐B domain of fibronectinInternational Journal of Cancer, 2002
- The fibronectin isoform containing the ed‐b oncofetal domain: A marker of angiogenesisInternational Journal of Cancer, 1994
- Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissuesInternational Journal of Cancer, 1994
- A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors.The Journal of cell biology, 1989